Tenax Therapeutics TENX
NASDAQ TENX
$1.98 +0.05 (+2.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Asset Writedowns and Impairment (2011 - 2016)

Updated

Tenax Therapeutics (TENX) reported Asset Writedowns and Impairment of $33.27 million for FY2016.

Analysis

Tenax Therapeutics (TENX) Asset Writedowns and Impairment (2011 - 2016) Analysis & Trends

Dating back to FY2011, Tenax Therapeutics' Asset Writedowns and Impairment record includes 5 years.

  • Asset Writedowns and Impairment has a five-year compound annual growth rate of 156.1% (FY2011 to FY2016).
  • The FY2016 figure ranks as the highest annual Asset Writedowns and Impairment in data going back to FY2011.
  • According to Business Quant data, Asset Writedowns and Impairment came in at $1.03 million in FY2015, $35,673 in FY2013 (-71.1%) and $123,518 in FY2012 (-59.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tenax Therapeutics 89.55 Mn 89.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 33.27 Mn
Apr 30, 2013 24,110.00
Apr 30, 2012 27,758.00
Jan 31, 2012 93,089.00
Oct 31, 2011 2,671.00
Apr 30, 2011 302,044.00
API Access

Tenax Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=TENX&period=max&api_key=YOUR_API_KEY